# EnhancedBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enhancedbio

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.enhancedbio.com
- Total disclosed funding: $15M
- Latest round: Series C (Dec 30, 2021)
- Investors on record: 23

## About

Based in Seoul, South Korea, and founded in 2016, EnhancedBio Inc. operates as a biopharmaceutical company that is developing therapies and drugs with the goal of providing cures for cancer disease patients. In August 2022, ENHANCEDBIO Inc raised KRW 12.5 billion in series C funding from new investors Seoul Investment Partners, Mirae Asset Venture Investment, Ideabridge Partners, DK Investment Partners, and others.

The company’s anti-cancer therapeutics product pipeline that is at its clinical stage of the trial includes borestrant, ER-PROTAC, BTK-PROTAC, cavisiran (+EN LNP), mevasiran (+EN LNP), and corpitenib, as well as technology EN LNP (Lipid Nano Particle) including LNP for mRNA-based vaccine, siRNA therapeutics, therapeutic protein replacement, genome editing and cell engineering.

## Funding rounds

- Series C, Dec 30, 2021, $7.1M — Korea Investment Management, Seoul Investment Partners, HB Investment, Mirae Asset Venture Investment, Heungkuk Securities, Idea Bridge Asset Management, Mobydick Ventures
- Series B, Aug 7, 2020, $8M — Hyundai Venture Investment, KDB Bank, HB Investment, JB Investment, Soorim Venture Capital, Lighthouse Combined Investment, Sunbo Angel Partners, Log Investment
- Series A, Jan 28, 2019 — CKD Venture Capital, Seoul Investment Partners, Samho Green Investment, Magna Investment, Hana Securities, Honest Ventures, Korea Venture Investment Corporation, ILJIN SNT, Dong-Yu Technology Investment, Friend Investment Partners

## Investors

- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series A
- Seoul Investment Partners (https://capitalatlas.ai/funds/seoul-investment-partners) — Series A, Series C
- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series A
- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Series A
- Hana Securities (https://capitalatlas.ai/funds/hana-securities) — Series A
- Honest Ventures (https://capitalatlas.ai/funds/honest-ventures) — Series A
- Korea Venture Investment Corporation (https://capitalatlas.ai/funds/korea-venture-investment-corporation) — Series A
- ILJIN SNT — Series A
- Dong-Yu Technology Investment (https://capitalatlas.ai/funds/dong-yu-technology-investment) — Series A
- Friend Investment Partners (https://capitalatlas.ai/funds/friend-investment-partners) — Series A
- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series B
- KDB Bank — Series B
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series B, Series C
- JB Investment (https://capitalatlas.ai/funds/jb-investment) — Series B
- Soorim Venture Capital (https://capitalatlas.ai/funds/soorim-venture-capital) — Series B
- Lighthouse Combined Investment (https://capitalatlas.ai/funds/lighthouse-combined-investment) — Series B
- Sunbo Angel Partners (https://capitalatlas.ai/funds/sunbo-angel-partners) — Series B
- Log Investment (https://capitalatlas.ai/funds/log-investment) — Series B
- Korea Investment Management — Series C
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series C
- Heungkuk Securities — Series C
- Idea Bridge Asset Management — Series C
- Mobydick Ventures (https://capitalatlas.ai/funds/mobydick-ventures) — Series C